Syringe prefilled with a colorless or pale-yellow liquid when reconstituted with lyophilized white crystalline pellet in a clear and colorless vial and an attached solvent (injection solution)

Attenuated varicella live virus

• Prevention of herpes zoster in adults 50 years of age or older

• This vaccine shall be injected subcutaneously at the lateral side of the upper arm as a one full dose (approximately 0.5 mL) and should not be injected intravascularly or intramuscularly.
• [Preparation and Administration Method]
  • To dissolve this vaccine, add the entire amount of the attached solvent to the vial containing the lyophilized vaccine (using a 23G needle) and shake the vial until it is completely dissolved.
  • Inject the entire amount (using 25 G needle) of this solution (approximately 0.5 mL) subcutaneously.
  • To minimize loss of titer, the vaccine should be administered immediately after preparation, and any vaccine that has not been used within 30 minutes after preparation should be discarded.

1 lyophilized vial [attached solvent (prefilled syringe): 0.7 mL included] x in-house package unit 1 lyophilized vial [attached solvent (vial): 0.7 mL included] x in-house package unit (only applicable for export)

Keep refrigerated at 2-8°C in an airtight container away from light.